MedTrace Logo

Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression

NCT00446901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-03-14

No results posted yet for this study

Summary

The aim of this study is to determine whether selenium supplementation leads to changes in selenium levels and gene expression profiles in prostate tissue.

Conditions

Interventions

DIETARY_SUPPLEMENT

Selenium

Selenized yeast, 300 ug/day

Sponsors & Collaborators

  • World Cancer Research Fund International

    collaborator OTHER

  • Wageningen University

    lead OTHER

Principal Investigators

  • J.A. Witjes, Md PhD Prof · University Medical Center St Radboud

  • L.A.L.M. Kiemeney, PhD Prof · University Medical Center St Radboud

  • P. van 't Veer, PhD Prof · Wageningen University

  • L.A. Afman, PhD · Wageningen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00446901 on ClinicalTrials.gov